Could MMP3 and MMP9 Serve as Biomarkers in EBV-Related Oropharyngeal Cancer
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25052561 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Anna Polz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Genomed S.A., 02-971 Warsaw, Poland. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Carcinoma, Squamous Cell, Head and Neck Neoplasms, Oropharyngeal Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lublin.
Abstract (Originalsprache)
The high incidence of, and mortality from, head and neck cancers (HNCs), including those related to Epstein–Barr virus (EBV), constitute a major challenge for modern medicine, both in terms of diagnosis and treatment. Therefore, many researchers have made efforts to identify diagnostic and prognostic factors. The aim of this study was to evaluate the diagnostic usefulness of matrix metalloproteinase 3 (MMP 3) and matrix metalloproteinase 9 (MMP 9) in EBV positive oropharyngeal squamous cell carcinoma (OPSCC) patients. For this purpose, the level of these MMPs in the serum of patients with EBV-positive OPSCC was analyzed in relation to the degree of histological differentiation and TNM classification. Our research team’s results indicate that the level of both MMPs is much higher in the EBV positive OPSCC patients compared to the EBV negative and control groups. Moreover, their levels were higher in more advanced clinical stages. Considering the possible correlation between the level of MMP 3, MMP 9 and anti-EBV antibodies, and also viral load, after statistical analysis using multiple linear regression, their high correlation was demonstrated. The obtained results confirm the diagnostic accuracy for MMP 3 and MMP 9. Both MMPs may be useful in the diagnosis of EBV positive OPSCC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genomed S.A., 02-971 Warsaw, Poland.
- Department of Otolaryngology Head and Neck Cancer, University of Technology and Humanities in Radom, 26-600 Radom, Poland.
- Department of Computer Science and Medical Statistics with e-health Laboratory, Medical University of Lublin, 20-090 Lublin, Poland.
- Department of Virology with Viral Diagnostics Laboratory, Medical University of Lublin, 20-093 Lublin, Poland.
ORCID-Profile: Kamal Morshed, Małgorzata Polz-Dacewicz
Förderung
- Medical University of Lublin
Zitieren
APA
Polz, A., Morshed, K., Drop, B., & Polz-Dacewicz, M. (2024). Could MMP3 and MMP9 Serve as Biomarkers in EBV-Related Oropharyngeal Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25052561
Vancouver
Polz A, Morshed K, Drop B, Polz-Dacewicz M. Could MMP3 and MMP9 Serve as Biomarkers in EBV-Related Oropharyngeal Cancer. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25052561
BibTeX
@article{Polz2024,
author = {Polz, Anna and Morshed, Kamal and Drop, Bartłomiej and Polz-Dacewicz, Małgorzata},
title = {Could MMP3 and MMP9 Serve as Biomarkers in EBV-Related Oropharyngeal Cancer},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25052561}
}
EUVIMED